AQR Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | $541K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $32.2K | Buy |
|
|||||
|
2023
Q2 | $64.3K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $89.8K | Sell |
|
|||||
|
2022
Q3 | $721K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $100K | Sell |
|
|||||
|
2021
Q4 | $470K | Sell |
|
|||||
|
2021
Q3 | $978K | Sell |
|
|||||
|
2021
Q2 | $1.49M | Buy |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | $415K | Sell |
|
|||||
|
2020
Q3 | $926K | Sell |
|
|||||
|
2020
Q2 | $2.4M | Sell |
|
|||||
|
2020
Q1 | $2.81M | Buy |
|
|||||
|
2019
Q4 | $2.44M | Buy |
|
|||||
|
2019
Q3 | $132K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $163K | Sell |
|
|||||
|
2017
Q2 | $386K | Sell |
|
|||||
|
2017
Q1 | $562K | Sell |
|
|||||
|
2016
Q4 | $1.31M | Sell |
|
|||||
|
2016
Q3 | $2.06M | Buy |
|
|||||
|
2016
Q2 | $1.48M | Buy |
|
|||||
|
2016
Q1 | $809K | Sell |
|
|||||
|
2015
Q4 | $968K | Buy |
|
|||||
|
2015
Q3 | $124K | Sell |
|
|||||
|
2015
Q2 | $305K | Buy |
|